Published in Adv Colloid Interface Sci on May 05, 2007
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol (2011) 2.98
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm (2008) 2.94
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res (2010) 2.70
Air pollution: mechanisms of neuroinflammation and CNS disease. Trends Neurosci (2009) 2.60
Toxicity of nanomaterials. Chem Soc Rev (2011) 2.07
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine (2008) 1.99
The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci (2010) 1.71
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res (2008) 1.28
Urban air pollution: influences on olfactory function and pathology in exposed children and young adults. Exp Toxicol Pathol (2009) 1.23
Surface characterization of nanomaterials and nanoparticles: Important needs and challenging opportunities. J Vac Sci Technol A (2013) 1.18
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci (2013) 1.16
Silver nanoparticle protein corona composition in cell culture media. PLoS One (2013) 1.13
On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol (2009) 1.13
The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnology (2010) 1.08
Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci Rep (2014) 1.06
Comparison of nanotube-protein corona composition in cell culture media. Small (2013) 1.06
Dynamic factors controlling targeting nanocarriers to vascular endothelium. Curr Drug Metab (2012) 1.02
Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol Pharm (2011) 1.01
Protonated nanoparticle surface governing ligand tethering and cellular targeting. ACS Nano (2009) 1.00
Applications of nanotechnology in dermatology. J Invest Dermatol (2012) 1.00
Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci (2014) 0.99
Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res (2014) 0.99
Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation. Part Fibre Toxicol (2013) 0.98
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol (2013) 0.96
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomedicine (2011) 0.95
Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation. J Nanotechnol Eng Med (2013) 0.95
Mapping the surface adsorption forces of nanomaterials in biological systems. ACS Nano (2011) 0.95
Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett (2013) 0.94
Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B (2012) 0.92
Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation. Int J Nanomedicine (2010) 0.92
Cellular Binding of Anionic Nanoparticles is Inhibited by Serum Proteins Independent of Nanoparticle Composition. Biomater Sci (2013) 0.91
An improved 3D tetraculture system mimicking the cellular organisation at the alveolar barrier to study the potential toxic effects of particles on the lung. Part Fibre Toxicol (2013) 0.90
In vitro interaction of colloidal nanoparticles with mammalian cells: What have we learned thus far? Beilstein J Nanotechnol (2014) 0.90
The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. Small (2012) 0.89
Hafnium oxide nanoparticles: toward an in vitro predictive biological effect? Radiat Oncol (2014) 0.88
Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir (2013) 0.88
Intracellular SERS nanoprobes for distinction of different neuronal cell types. Nano Lett (2013) 0.87
Toxicity and cellular uptake of gold nanorods in vascular endothelium and smooth muscles of isolated rat blood vessel: importance of surface modification. Small (2012) 0.86
Nanoscale interfaces to biology. Curr Opin Chem Biol (2010) 0.85
Exploration of possible binding sites of nanoparticles on protein by cross-linking chemistry coupled with mass spectrometry. Anal Chem (2011) 0.83
The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles. Int J Nanomedicine (2015) 0.83
Gold nanoprobes for theranostics. Nanomedicine (Lond) (2011) 0.82
Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.82
Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci Rep (2015) 0.81
Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles. PLoS One (2012) 0.81
Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform. PLoS One (2014) 0.81
Protein expression profiles of intestinal epithelial co-cultures: effect of functionalised carbon nanotube exposure. Int J Biomed Nanosci Nanotechnol (2013) 0.80
Gastrointestinal biodurability of engineered nanoparticles: Development of an in vitro assay. Nanotoxicology (2009) 0.80
Sequestration of nanoparticles by an EPS matrix reduces the particle-specific bactericidal activity. Sci Rep (2016) 0.79
Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles - a fluorescence correlation spectroscopy study. Beilstein J Nanotechnol (2014) 0.79
Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab (2013) 0.78
Issues and applications in label-free quantitative mass spectrometry. Int J Proteomics (2013) 0.78
Hydroxy-terminated conjugated polymer nanoparticles have near-unity bright fraction and reveal cholesterol-dependence of IGF1R nanodomains. ACS Nano (2013) 0.78
Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake. J Nanobiotechnology (2014) 0.77
Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye. Jpn J Ophthalmol (2009) 0.77
Buoyant Nanoparticles: Implications for Nano-Biointeractions in Cellular Studies. Small (2016) 0.77
DnaK protein alleviates toxicity induced by citrate-coated gold nanoparticles in Escherichia coli. PLoS One (2015) 0.77
Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages. PLoS One (2015) 0.76
Mutagenic Effects of Iron Oxide Nanoparticles on Biological Cells. Int J Mol Sci (2015) 0.76
Protein adsorption onto nanoparticles induces conformational changes: Particle size dependency, kinetics, and mechanisms. Eng Life Sci (2015) 0.76
Rapid Kinetics of Size and pH-Dependent Dissolution and Aggregation of Silver Nanoparticles in Simulated Gastric Fluid. J Phys Chem C Nanomater Interfaces (2015) 0.75
Autophagy as a Possible Underlying Mechanism of Nanomaterial Toxicity. Nanomaterials (Basel) (2014) 0.75
High Throughput Screening Method to Explore Protein Interactions with Nanoparticles. PLoS One (2015) 0.75
Application of ZnO Nanoparticles for Improving the Thermal and pH Stability of Crude Cellulase Obtained from Aspergillus fumigatus AA001. Front Microbiol (2016) 0.75
Peptide-biphenyl hybrid-capped AuNPs: stability and biocompatibility under cell culture conditions. Nanoscale Res Lett (2013) 0.75
Characterisation of the protein corona using tunable resistive pulse sensing: determining the change and distribution of a particle's surface charge. Anal Bioanal Chem (2016) 0.75
Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.75
High performance magneto-fluorescent nanoparticles assembled from terbium and gadolinium 1,3-diketones. Sci Rep (2017) 0.75
The Gold Nanorod-Biology Interface: From Proteins to Cells to Tissue. Curr Phys Chem (2013) 0.75
Super-sensitive time-resolved fluoroimmunoassay for thyroid-stimulating hormone utilizing europium(III) nanoparticle labels achieved by protein corona stabilization, short binding time, and serum preprocessing. Anal Bioanal Chem (2017) 0.75
Protein Corona-Induced Modification of Silver Nanoparticle Aggregation in Simulated Gastric Fluid. Environ Sci Nano (2016) 0.75
The nanoparticle protein corona formed in human blood or human blood fractions. PLoS One (2017) 0.75
Synthesis of bimetallic platinum nanoparticles for biosensors. Sensors (Basel) (2013) 0.75
Exploring gold nanoparticle interactions with proteins and the tumor microenvironment in biological systems. Transl Cancer Res (2017) 0.75
Protein structural changes induced by glutathione-coated CdS quantum dots as revealed by Trp phosphorescence. Eur Biophys J (2011) 0.75
ROS generation and DNA damage with photo-inactivation mediated by silver nanoparticles in lung cancer cell line. IET Nanobiotechnol (2017) 0.75
Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state. Sci Rep (2017) 0.75
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
The La protein. Annu Rev Biochem (2001) 3.32
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 2.59
Methods for the detection and analysis of protein-protein interactions. Proteomics (2007) 2.29
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol (2011) 1.90
Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci (2009) 1.75
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J (2009) 1.71
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Structure and functional properties of the Bacillus subtilis transcriptional repressor Rex. Mol Microbiol (2008) 1.49
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) (2011) 1.43
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release (2012) 1.41
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One (2010) 1.34
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
Measurement of Ca2+-binding constants of proteins and presentation of the CaLigator software. Anal Biochem (2002) 1.34
A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci U S A (2003) 1.31
Calbindin D28k exhibits properties characteristic of a Ca2+ sensor. J Biol Chem (2002) 1.29
Residue-specific pKa determination of lysine and arginine side chains by indirect 15N and 13C NMR spectroscopy: application to apo calmodulin. J Am Chem Soc (2007) 1.25
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett (2008) 1.25
Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small (2011) 1.25
The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine (2013) 1.25
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J Proteome Res (2006) 1.21
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol (2009) 1.20
Nanotoxicology: nanoparticles reconstruct lipids. Nat Nanotechnol (2009) 1.19
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci (2010) 1.14
Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials (2006) 1.10
Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J (2007) 1.09
Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol (2011) 1.09
Protein reconstitution and three-dimensional domain swapping: benefits and constraints of covalency. Protein Sci (2007) 1.08
Classification framework for graphene-based materials. Angew Chem Int Ed Engl (2014) 1.06
Surface effects on aggregation kinetics of amyloidogenic peptides. J Am Chem Soc (2014) 1.06
Isolation and detection of human IgA using a streptococcal IgA-binding peptide. J Immunol (2002) 1.06
Calmodulin binding to the polybasic C-termini of STIM proteins involved in store-operated calcium entry. Biochemistry (2008) 1.06
Salting the charged surface: pH and salt dependence of protein G B1 stability. Biophys J (2006) 1.05
HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects. Adv Cancer Res (2003) 1.05
Myo-inositol monophosphatase is an activated target of calbindin D28k. J Biol Chem (2002) 1.05
Quantification of the concentration of Aβ42 propagons during the lag phase by an amyloid chain reaction assay. J Am Chem Soc (2013) 1.03
Novel method to prepare morphologically rich polymeric surfaces for biomedical applications via phase separation and arrest of microgel particles. J Phys Chem B (2006) 1.03
Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.03
Biophysical characterization of the unstructured cytoplasmic domain of the human neuronal adhesion protein neuroligin 3. Biophys J (2008) 1.03
In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol (2009) 1.02
Correlation signature of the macroscopic states of the gene regulatory network in cancer. Proc Natl Acad Sci U S A (2009) 1.01
High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLoS One (2012) 1.01
Interaction of soft condensed materials with living cells: phenotype/transcriptome correlations for the hydrophobic effect. Proc Natl Acad Sci U S A (2003) 1.00
pK(a) values for side-chain carboxyl groups of a PGB1 variant explain salt and pH-dependent stability. Biophys J (2006) 1.00
Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir (2012) 0.99
Membrane interaction of α-synuclein in different aggregation states. J Parkinsons Dis (2011) 0.98
The role of electrostatic interactions in calmodulin-peptide complex formation. Biophys J (2004) 0.98
High-speed imaging of Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells. ACS Nano (2012) 0.98
Lipids as cofactors in protein folding: stereo-specific lipid-protein interactions are required to form HAMLET (human alpha-lactalbumin made lethal to tumor cells). Protein Sci (2003) 0.98
On the lag phase in amyloid fibril formation. Phys Chem Chem Phys (2015) 0.98
Coupling of ligand binding and dimerization of helix-loop-helix peptides: spectroscopic and sedimentation analyses of calbindin D9k EF-hands. Proteins (2002) 0.97
Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem J (2005) 0.97
BRICHOS domains efficiently delay fibrillation of amyloid β-peptide. J Biol Chem (2012) 0.97
Structural changes in apolipoproteins bound to nanoparticles. Langmuir (2011) 0.96
A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. Nanoscale (2011) 0.96
Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog (2006) 0.96
Protein reconstitution and 3D domain swapping. Curr Protein Pept Sci (2002) 0.93
TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascul Pharmacol (2006) 0.93
Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety. Nanoscale (2014) 0.93
Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology (2010) 0.93
Unfolding a folding disease: folding, misfolding and aggregation of the marble brain syndrome-associated mutant H107Y of human carbonic anhydrase II. J Mol Biol (2004) 0.92
Electrostatic contributions to residue-specific protonation equilibria and proton binding capacitance for a small protein. Biochemistry (2006) 0.92
Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology (2010) 0.91
Elution of labile fluorescent dye from nanoparticles during biological use. PLoS One (2011) 0.90
The ALS-associated mutation G93A in human copper-zinc superoxide dismutase selectively destabilizes the remote metal binding region. Biochemistry (2009) 0.90
Calcium binding, structural stability and guanylate cyclase activation in GCAP1 variants associated with human cone dystrophy. Cell Mol Life Sci (2010) 0.89
Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. ACS Chem Neurosci (2013) 0.89